亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯(lián)系方式|購物車
企業(yè)會員第1年

武漢康寶泰精細化工有限公司武昌一部  

醫(yī)藥中間體,維生素,植物提取物

搜索
新聞中心
  • 暫無新聞
產(chǎn)品分類
  • 暫無分類
聯(lián)系方式
  • 聯(lián)系人:付經(jīng)理
  • 電話:027-87738695
  • 郵件:664219562@qq.com
  • 傳真:027-87738652
  • QQ:664219562
站內(nèi)搜索
 
榮譽資質(zhì)
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應(yīng)產(chǎn)品 > 5-甲基尿甙 1463-10-1
5-甲基尿甙 1463-10-1
單價 1.00 / 千克對比
銷量 暫無
發(fā)貨 湖北武漢市付款后3天內(nèi)
庫存 1000千克起訂1千克
品牌 康寶泰
型號 1463-10-1
規(guī)格 25
過期 長期有效
更新 2013-11-28 11:21
 
詳細信息
中文名稱: 5-甲基尿甙
中文同義詞: 5-甲基尿甙;5-甲基尿苷;5-甲基尿嘧啶核苷;5-甲基鳥苷;5-甲基尿;5-甲基尿嘧啶核苷(5-甲基尿苷)
英文名稱: 5-Methyluridine
英文同義詞: 5-METHYLURIDINE;5-METHYL-D-URIDINE;5-METHYL-1-BETA-D-RIBOFURANOSYL URACIL;1-(BETA-D-RIBOFURANOSYL)THYMIDINE;1-(BETA-D-RIBOFURANOSYL)THYMINE;BETA-D-THYMINE RIBOSIDE;BETA-RIBOFURANOSIDE;ribosylthymine
CAS號: 1463-10-1
分子式: C10H14N2O6
分子量: 258.23
EINECS號: 215-973-9
熔點  183-184 °C(lit.)
 儲存條件  2-8°C
 form  powder
 color  white
 CAS 數(shù)據(jù)庫 1463-10-1(CAS DataBase Reference)

©2025 武漢康寶泰精細化工有限公司武昌一部 版權(quán)所有   技術(shù)支持:化工網(wǎng)   訪問量:16944  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |